Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Developmental Dysplasia of the Hip

  • Author: Junichi Tamai, MD; Chief Editor: William L Jaffe, MD  more...
 
Updated: Jul 21, 2016
 

Background

The term congenital dislocation of the hip dates back to the time of Hippocrates. This condition, also known as hip dysplasia or developmental dysplasia of the hip (DDH), has been diagnosed and treated for several hundred years. Most notably, Ortolani, an Italian pediatrician in the early 1900s, evaluated, diagnosed, and began treating hip dysplasia. Galeazzi later reviewed more than 12,000 cases of DDH and reported the association between apparent shortening of the flexed femur and hip dislocation. Since then, significant progress has been made in the evaluation and treatment of DDH.[1, 2, 3, 4, 5]

The definition of DDH is not universally agreed upon. Typically, the term DDH is used in referring to patients who are born with dislocation or instability of the hip, which may then result in hip dysplasia. More broadly, DDH may be defined simply as abnormal growth of the hip. Abnormal development of the hip includes the osseous structures, such as the acetabulum and the proximal femur, as well as the labrum, capsule, and other soft tissues. This condition may occur at any time, from conception to skeletal maturity. The author prefers to use the term hip dysplasia, considering it both simpler and more accurate. Internationally, this disorder is still referred to as congenital dislocation of the hip.

More specific terms are often used to describe the condition more precisely; these are defined as follows:

  • Subluxation – Incomplete contact between the articular surfaces of the femoral head and acetabulum
  • Dislocation – Complete loss of contact between the articular surface of the femoral head and acetabulum
  • Instability – Ability to subluxate or dislocate the hip with passive manipulation
  • Teratologic dislocation – Antenatal dislocation of the hip

Early diagnosis is the most crucial aspect of the treatment of children with DDH. The use of ultrasonography and other diagnostic imaging modalities and the implementation of improved educational programs will most likely decrease the number of children with DDH who are diagnosed late. Newer, less invasive surgical techniques (eg, endoscopic techniques and image-guided surgery) are being developed in an effort to decrease the morbidity of surgery and to ease recovery.

Next

Anatomy

The normal growth of the acetabulum depends on normal epiphyseal growth of the triradiate cartilage and on the three ossification centers located within the acetabular portion of the pubis (os acetabulum), ilium (acetabular epiphysis), and ischium. Additionally, normal growth of the acetabulum depends on normal interstitial appositional growth within the acetabulum. The presence of the spherical femoral head within the acetabulum is critical for stimulating normal development of the acetabulum.

The anatomy of the dislocated hip, especially after several months, often includes formation of a ridge called the neolimbus. Closed reduction is often unsuccessful at a later date, secondary to various obstacles to reduction. These include adductor and psoas tendon contraction, ligamentous teres, a transverse acetabular ligament, and pulvinar and capsular constriction. With long-standing dislocations, interposition of the labrum can also interfere with reduction.

Previous
Next

Pathophysiology

DDH involves abnormal growth of the hip. Ligamentous laxity is also believed to be associated with hip dysplasia, though this association is less clear. DDH is not part of the classic description of disorders that are associated with significant ligamentous laxity, such as Ehlers-Danlos syndrome or Marfan syndrome.

Children often have ligamentous laxity at birth, yet their hips are not usually unstable; in fact, it takes a great deal of effort to dislocate a child's hip. Therefore, more than just ligamentous laxity may be required to result in DDH. At birth, white children tend to have a shallow acetabulum.[6, 7] ; this may provide a susceptible period in which abnormal positioning or a brief period of ligamentous laxity may result in hip instability. However, this characteristic is not as true for children of African descent, who have a lower rate of DDH.[8]

Previous
Next

Etiology

The etiology of hip dysplasia is not clear, but this condition does appear to be related to a number of different factors.[9] One such factor is racial background: In Native Americans and Laplanders, the prevalence of hip dysplasia is much higher (nearly 25-50 cases per 1000 persons) than in other races, and the prevalence is very low in southern Chinese and black populations.[10, 11, 12, 8] An underlying genetic disposition also appears to exist, in that the frequency of hip dysplasia is 10 times higher in children whose parents had DDH than in those whose parents did not.[13]

Other factors possibly related to DDH include intrauterine positioning and sex, and some of these are interrelated. Female sex, being the first-born child, and breech positioning are all associated with an increased prevalence of DDH. An estimated 80% of persons with DDH are female,[14] and the rate of breech positioning in children with DDH is approximately 20% (compared with 2-4% in the general population).[15, 16] The prevalence of DDH in females born in breech position has been estimated to be as high as 1 case in 15 persons in some studies.[17]

Other musculoskeletal disorders of intrauterine malpositioning or crowding, such as metatarsus adductus and torticollis, have been reported to be associated with DDH.[18, 19] Oligohydramnios is also reported to be associated with an increased prevalence of DDH.[20] The left hip is more commonly associated with DDH than the right hip, possibly because of the common intrauterine position of the left hip against the mother's sacrum, which forces it into an adducted position.[20] Children in cultures in which the mother swaddles the baby, forcing the infant's hips to be adducted, also have a higher rate of hip dysplasia.[21]

Hip dysplasia can be associated with underlying neuromuscular disorders, such as cerebral palsy, myelomeningocele, arthrogryposis, and Larsen syndrome, though such cases are not usually considered DDH.

Previous
Next

Epidemiology

The overall frequency of DDH is usually reported as approximately 1 case per 1000 individuals, though Barlow believed that the incidence of hip instability during newborn examinations was as high as 1 case per 60 newborns.[22] According to Barlow's study, more than 60% of newborns with hip instability became stable by age 1 week, and 88% became stable by age 2 months, leaving only 12% (of the 1 in 60 newborns, or 0.2% overall) with residual hip instability.

Previous
Next

Prognosis

Overall, the prognosis for children treated for hip dysplasia is very good, especially if the dysplasia is managed with closed treatment. If closed treatment is unsuccessful and open reduction is needed, the outcome may be less favorable[23] , although the short-term outcome appears to be satisfactory. If secondary procedures are needed to obtain reduction, then the overall outcome is significantly worse.

Some authors believe that patients with bilateral hip dysplasia have a poorer prognosis because of frequent delays in diagnosis and greater treatment requirements.[24, 25] In a study comparing the outcomes of walking-age children with bilateral hip dislocations who underwent open reduction and pelvic osteotomy with or without femoral osteotomy with those of walking-age children with unilateral dislocated hips who underwent the same set of procedures, the radiographic outcomes were similar.[26]

In this study, the rate of osteonecrosis was higher in the bilateral group, but this difference was explained by older age at surgery and a greater degree of hip dislocation before surgery.[26] The authors concluded that the clinical outcomes after surgery of the children with bilateral hip dislocations were worse mainly because of asymmetric outcomes.

Previous
 
 
Contributor Information and Disclosures
Author

Junichi Tamai, MD Assistant Professor, Division of Pediatric Orthopaedics, Director of Physician Assistants, Cincinnati Children’s Hospital Medical Center; Assistant Professor of Clinical Orthopaedic Surgery Affiliated, Department of Orthopaedics, University of Cincinnati College of Medicine

Junichi Tamai, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Academy of Pediatrics, American Medical Association, Pediatric Orthopaedic Society of North America, Cincinnati Pediatric Society

Disclosure: Received honoraria from Oakstone Board Review for speaking and teaching.

Coauthor(s)

James J McCarthy, MD, FAAOS, FAAP Director, Division of Orthopedic Surgery, Cincinnati Children's Hospital; Professor, Department of Orthopedic Surgery, University of Cincinnati College of Medicine

James J McCarthy, MD, FAAOS, FAAP is a member of the following medical societies: American Academy of Pediatrics, American Orthopaedic Association, Pennsylvania Medical Society, Philadelphia County Medical Society, Pennsylvania Orthopaedic Society, Pediatric Orthopaedic Society of North America, Orthopaedics Overseas, Limb Lengthening and Reconstruction Society, Alpha Omega Alpha, American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Orthopaedic Surgeons

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Orthopediatrics, Phillips Healthcare, POSNA<br/>Serve(d) as a speaker or a member of a speakers bureau for: Synthes<br/>Received research grant from: University of Cincinnati<br/>Received royalty from Lippincott Williams and WIcins for editing textbook; Received none from POSNA for board membership; Received none from LLRS for board membership; Received consulting fee from Synthes for none.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

B Sonny Bal, MD, JD, MBA Professor, Department of Orthopedic Surgery, University of Missouri-Columbia School of Medicine

B Sonny Bal, MD, JD, MBA is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Received none from Bonesmart.org for online orthopaedic marketing and information portal; Received none from OrthoMind for social networking for orthopaedic surgeons; Received stock options and compensation from Amedica Corporation for manufacturer of orthopaedic implants; Received ownership interest from BalBrenner LLC for employment; Received none from ConforMIS for consulting; Received none from Microport for consulting.

Chief Editor

William L Jaffe, MD Clinical Professor of Orthopedic Surgery, New York University School of Medicine; Vice Chairman, Department of Orthopedic Surgery, New York University Hospital for Joint Diseases

William L Jaffe, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American College of Surgeons, Eastern Orthopaedic Association, New York Academy of Medicine

Disclosure: Received consulting fee from Stryker Orthopaedics for speaking and teaching.

Additional Contributors

B Sonny Bal, MD, JD, MBA Professor, Department of Orthopedic Surgery, University of Missouri-Columbia School of Medicine

B Sonny Bal, MD, JD, MBA is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Received none from Bonesmart.org for online orthopaedic marketing and information portal; Received none from OrthoMind for social networking for orthopaedic surgeons; Received stock options and compensation from Amedica Corporation for manufacturer of orthopaedic implants; Received ownership interest from BalBrenner LLC for employment; Received none from ConforMIS for consulting; Received none from Microport for consulting.

References
  1. Sankar WN, Weiss J, Skaggs DL. Orthopaedic conditions in the newborn. J Am Acad Orthop Surg. 2009 Feb. 17(2):112-22. [Medline].

  2. Karmazyn BK, Gunderman RB, Coley BD, Blatt ER, Bulas D, Fordham L. ACR Appropriateness Criteria on developmental dysplasia of the hip--child. J Am Coll Radiol. 2009 Aug. 6(8):551-7. [Medline].

  3. AIUM practice guideline for the performance of an ultrasound examination for detection and assessment of developmental dysplasia of the hip. J Ultrasound Med. 2009 Jan. 28(1):114-9. [Medline].

  4. Janssen D, Kalchschmidt K, Katthagen BD. Triple pelvic osteotomy as treatment for osteoarthritis secondary to developmental dysplasia of the hip. Int Orthop. 2009 Feb 12. [Medline].

  5. El-Sayed M, Ahmed T, Fathy S, Zyton H. The effect of Dega acetabuloplasty and Salter innominate osteotomy on acetabular remodeling monitored by the acetabular index in walking DDH patients between 2 and 6 years of age: short- to middle-term follow-up. J Child Orthop. 2012 Dec. 6(6):471-477. [Medline]. [Full Text].

  6. McKibbin B. Anatomical factors in the stability of the hip joint in the newborn. J Bone Joint Surg Br. 1970 Feb. 52(1):148-59. [Medline]. [Full Text].

  7. Rális Z, McKibbin B. Changes in shape of the human hip joint during its development and their relation to its stability. J Bone Joint Surg Br. 1973 Nov. 55(4):780-5. [Medline]. [Full Text].

  8. Skirving AP, Scadden WJ. The African neonatal hip and its immunity from congenital dislocation. J Bone Joint Surg Br. 1979 Aug. 61-B(3):339-41. [Medline]. [Full Text].

  9. Ziegler J, Thielemann F, Mayer-Athenstaedt C, Günther KP. [The natural history of developmental dysplasia of the hip: A metaanalysis of the published literature] [German]. Orthopade. 2008 May 17. epub ahead of print. [Medline].

  10. Getz B. The hip joint in Lapps and its bearing on the problem of congenital dislocation. Acta Orthop Scand Suppl. 1955. 18:1-81. [Medline].

  11. Hoaglund FT, Yau AC, Wong WL. Osteoarthritis of the hip and other joints in southern Chinese in Hong Kong. J Bone Joint Surg Am. 1973 Apr. 55(3):545-57. [Medline].

  12. Rabin DL, Barnett CR, Arnold WD, Freiberger RH, Brooks G. Untreated congenital hip disease: a study of the epidemiology, natural history, and social aspects of the disease in a Navajo population. Am J Public Health Nations Health. 1965 Feb. 55(suppl):1-44. [Medline].

  13. Bjerkreim I, Arseth PH. Congenital dislocation of the hip in Norway. Late diagnosis CDH in the years 1970 to 1974. Acta Paediatr Scand. 1978 May. 67(3):329-32. [Medline].

  14. Wilkinson JA. A post-natal survey for congenital displacement of the hip. J Bone Joint Surg Br. 1972 Feb. 54(1):40-9. [Medline]. [Full Text].

  15. Carter CO, Wilkinson JA. Genetic and environmental factors in the etiology of congenital dislocation of the hip. Clin Orthop Relat Res. 1964 Mar-Apr. 33:119-28. [Medline].

  16. Salter RB. Etiology, pathogenesis and possible prevention of congenital dislocation of the hip. Can Med Assoc J. 1968 May 18. 98(20):933-45. [Medline]. [Full Text].

  17. Ramsey PL, Lasser S, MacEwen GD. Congenital dislocation of the hip. Use of the Pavlik harness in the child during the first six months of life. J Bone Joint Surg Am. 1976 Oct. 58(7):1000-4. [Medline]. [Full Text].

  18. Kumar SJ, MacEwen GD. The incidence of hip dysplasia with metatarsus adductus. Clin Orthop Relat Res. 1982 Apr. 164:234-5. [Medline].

  19. Weiner DS. Congenital dislocation of the hip associated with congenital muscular torticollis. Clin Orthop Relat Res. 1976 Nov-Dec. 121:163-5. [Medline].

  20. Dunn PM. Perinatal observations on the etiology of congenital dislocation of the hip. Clin Orthop Relat Res. 1976 Sep. 119:11-22. [Medline].

  21. Kutlu A, Memik R, Mutlu M, Kutlu R, Arslan A. Congenital dislocation of the hip and its relation to swaddling used in Turkey. J Pediatr Orthop. 1992 Sep-Oct. 12(5):598-602. [Medline].

  22. Barlow TG. Early diagnosis and treatment of congenital dislocation of the hip. J Bone Joint Surg Br. 1962. 44-B:292-301. [Full Text].

  23. Sankar WN, Young CR, Lin AG, Crow SA, Baldwin KD, Moseley CF. Risk Factors for Failure After Open Reduction for DDH: A Matched Cohort Analysis. J Pediatr Orthop. 2011 Apr-May. 31(3):232-9. [Medline].

  24. Greene WB, Drennan JC. A comparative study of bilateral versus unilateral congenital dislocation of the hip. Clin Orthop Relat Res. 1982 Jan-Feb. (162):78-86. [Medline].

  25. Zionts LE, MacEwen GD. Treatment of congenital dislocation of the hip in children between the ages of one and three years. J Bone Joint Surg Am. 1986 Jul. 68(6):829-46. [Medline].

  26. Wang TM, Wu KW, Shih SF, Huang SC, Kuo KN. Outcomes of open reduction for developmental dysplasia of the hip: does bilateral dysplasia have a poorer outcome?. J Bone Joint Surg Am. 2013 Jun 19. 95(12):1081-6. [Medline].

  27. Bond CD, Hennrikus WL, DellaMaggiore ED. Prospective evaluation of newborn soft-tissue hip "clicks" with ultrasound. J Pediatr Orthop. 1997 Mar-Apr. 17(2):199-201. [Medline].

  28. Darmonov AV, Zagora S. Clinical screening for congenital dislocation of the hip. J Bone Joint Surg Am. 1996 Mar. 78(3):383-8. [Medline].

  29. Ortolani M. Congenital hip dysplasia in the light of early and very early diagnosis. Clin Orthop Relat Res. 1976 Sep. 119:6-10. [Medline].

  30. Liu R, Li Y, Bai C, Song Q, Wang K. Effect of preoperative limb-length discrepancy on abductor strength after total hip arthroplasty in patients with developmental dysplasia of the hip. Arch Orthop Trauma Surg. 2013 Dec 3. [Medline].

  31. Mahan ST, Katz JN, Kim YJ. To screen or not to screen? A decision analysis of the utility of screening for developmental dysplasia of the hip. J Bone Joint Surg Am. 2009 Jul. 91(7):1705-19. [Medline]. [Full Text].

  32. Undefined.

  33. Fogarty EE, Accardo NJ Jr. Incidence of avascular necrosis of the femoral head in congenital hip dislocation related to the degree of abduction during preliminary traction. J Pediatr Orthop. 1981. 1(3):307-11. [Medline].

  34. Schoenecker PL, Bitz M, Witeside LA. The acute effect of position of immobilization on capital femoral epiphyseal blood flow. A quantitative study using the hydrogen washout technique. J Bone Joint Surg Am. 1978 Oct. 60(7):899-904. [Medline]. [Full Text].

  35. Tiderius C, Jaramillo D, Connolly S, Griffey M, Rodriguez DP, Kasser JR, et al. Post-closed reduction perfusion magnetic resonance imaging as a predictor of avascular necrosis in developmental hip dysplasia: a preliminary report. J Pediatr Orthop. 2009 Jan-Feb. 29(1):14-20. [Medline].

  36. Dogruel H, Atalar H, Yavuz OY, Sayli U. Clinical examination versus ultrasonography in detecting developmental dysplasia of the hip. Int Orthop. 2008 Jun. 32(3):415-9. [Medline].

  37. Henle P, Tannast M, Siebenrock KA. [Imaging in developmental dysplasia of the hip] [German]. Orthopade. 2008 May 23. [Medline].

  38. Gunay C, Atalar H, Dogruel H, et al. Correlation of femoral head coverage and Graf alpha angle in infants being screened for developmental dysplasia of the hip. Int Orthop. 2008 May 21. epub ahead of print. [Medline].

  39. Falliner A, Hahne HJ, Hassenpflug J. Sonographic hip screening and early management of developmental dysplasia of the hip. J Pediatr Orthop B. 1999 Apr. 8(2):112-7. [Medline].

  40. Paton RW, Srinivasan MS, Shah B, Hollis S. Ultrasound screening for hips at risk in developmental dysplasia. Is it worth it?. J Bone Joint Surg Br. 1999 Mar. 81(2):255-8. [Medline]. [Full Text].

  41. Hernandez RJ, Cornell RG, Hensinger RN. Ultrasound diagnosis of neonatal congenital dislocation of the hip. A decision analysis assessment. J Bone Joint Surg Br. 1994 Jul. 76(4):539-43. [Medline]. [Full Text].

  42. Clarke NM, Clegg J, Al-Chalabi AN. Ultrasound screening of hips at risk for CDH. Failure to reduce the incidence of late cases. J Bone Joint Surg Br. 1989 Jan. 71(1):9-12. [Medline]. [Full Text].

  43. Harcke HT, Kumar SJ. The role of ultrasound in the diagnosis and management of congenital dislocation and dysplasia of the hip. J Bone Joint Surg Am. 1991 Apr. 73(4):622-8. [Medline]. [Full Text].

  44. Graf R. The diagnosis of congenital hip-joint dislocation by the ultrasonic Combound treatment. Arch Orthop Trauma Surg. 1980. 97(2):117-33. [Medline].

  45. Macnicol MF. Results of a 25-year screening programme for neonatal hip instability. J Bone Joint Surg Br. 1990 Nov. 72(6):1057-60. [Medline]. [Full Text].

  46. Scoles PV, Boyd A, Jones PK. Roentgenographic parameters of the normal infant hip. J Pediatr Orthop. 1987 Nov-Dec. 7(6):656-63. [Medline].

  47. Wakabayashi K, Wada I, Horiuchi O, Mizutani J, Tsuchiya D, Otsuka T. MRI findings in residual hip dysplasia. J Pediatr Orthop. 2011 Jun. 31(4):381-7. [Medline].

  48. Chin MS, Betz BW, Halanski MA. Comparison of hip reduction using magnetic resonance imaging or computed tomography in hip dysplasia. J Pediatr Orthop. 2011 Jul-Aug. 31(5):525-9. [Medline].

  49. Jäger M, Westhoff B, Zilkens C, et al. [Indications and results of corrective pelvic osteotomies in developmental dysplasia of the hip] [German]. Orthopade. 2008 May 21. epub ahead of print. [Medline].

  50. Wedge JH, Wasylenko MJ. The natural history of congenital dislocation of the hip: a critical review. Clin Orthop Relat Res. 1978 Nov-Dec. 137:154-62. [Medline].

  51. Günther KP, Thielemann F, Hartmann A, Bernstein P. [Combined hip-dysplasia and femuroacetabular impingement: diagnosis and simultaneous surgical treatment] [German]. Orthopade. 2008 May 30. epub ahead of print. [Medline].

  52. Milgram JW. Morphology of untreated bilateral congenital dislocation of the hips in a seventy-four-year-old man. Clin Orthop Relat Res. 1976 Sep. 119:112-5. [Medline].

  53. Wiberg G. Studies on dysplastic acetabula and congenital subluxation of the hip joint, with special reference to the complication of osteoarthritis. Acta Chir Scand. 1939. 83(suppl 58):

  54. Cooperman DR, Wallensten R, Stulberg SD. Acetabular dysplasia in the adult. Clin Orthop. 1983 May. (175):79-85. [Medline].

  55. Stulberg SD, Harris WH. Acetabular dysplasia and development of osteoarthritis of the hip. Harris WH, ed. The Hip: Proceedings of the Second Open Meeting of the Hip Society. St. Louis, Mo: CV Mosby; 1974. 82.

  56. Mubarak S, Garfin S, Vance R, McKinnon B, Sutherland D. Pitfalls in the use of the Pavlik harness for treatment of congenital dysplasia, subluxation, and dislocation of the hip. J Bone Joint Surg Am. 1981 Oct. 63(8):1239-48. [Medline]. [Full Text].

  57. Pavlik A. The functional method of treatment using a harness with stirrups as the primary method of conservative therapy for infants with congenital dislocation of the hip. 1957. Clin Orthop Relat Res. 1992 Aug. 281:4-10. [Medline].

  58. Viere RG, Birch JG, Herring JA, Roach JW, Johnston CE. Use of the Pavlik harness in congenital dislocation of the hip. An analysis of failures of treatment. J Bone Joint Surg Am. 1990 Feb. 72(2):238-44. [Medline]. [Full Text].

  59. Kitoh H, Kawasumi M, Ishiguro N. Predictive factors for unsuccessful treatment of developmental dysplasia of the hip by the Pavlik harness. J Pediatr Orthop. 2009 Sep. 29(6):552-7. [Medline].

  60. Westacott DJ, Mackay ND, Waton A, Webb MS, Henman P, Cooke SJ. Staged weaning versus immediate cessation of Pavlik harness treatment for developmental dysplasia of the hip. J Pediatr Orthop B. 2013 Dec 5. [Medline].

  61. Suzuki S. Ultrasound and the Pavlik harness in CDH. J Bone Joint Surg Br. 1993 May. 75(3):483-7. [Medline]. [Full Text].

  62. Harding MG, Harcke HT, Bowen JR, Guille JT, Glutting J. Management of dislocated hips with Pavlik harness treatment and ultrasound monitoring. J Pediatr Orthop. 1997 Mar-Apr. 17(2):189-98. [Medline].

  63. Lerman JA, Emans JB, Millis MB, et al. Early failure of Pavlik harness treatment for developmental hip dysplasia: clinical and ultrasound predictors. J Pediatr Orthop. 2001 May-Jun. 21(3):348-53. [Medline].

  64. Borowski A, Thawrani D, Grissom L, Littleton AG, Thacker MM. Bilaterally dislocated hips treated with the Pavlik harness are not at a higher risk for failure. J Pediatr Orthop. 2009 Oct-Nov. 29(7):661-5. [Medline].

  65. van der Sluijs JA, De Gier L, Verbeke JI, Witbreuk MM, Pruys JE, van Royen BJ. Prolonged treatment with the Pavlik harness in infants with developmental dysplasia of the hip. J Bone Joint Surg Br. 2009 Aug. 91(8):1090-3. [Medline].

  66. Bialik GM, Eidelman M, Katzman A, Peled E. Treatment duration of developmental dysplasia of the hip: age and sonography. J Pediatr Orthop B. 2009 Jul 9. [Medline].

  67. Hedequist D, Kasser J, Emans J. Use of an abduction brace for developmental dysplasia of the hip after failure of Pavlik harness use. J Pediatr Orthop. 2003 Mar-Apr. 23(2):175-7. [Medline].

  68. Weinstein SL. Developmental hip dysplasia and dislocation. Morrissy RT, Weinstein SL, eds. Lovell and Winter's Pediatric Orthopaedics. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001. 905-35.

  69. Fish DN, Herzenberg JE, Hensinger RN. Current practice in use of prereduction traction for congenital dislocation of the hip. J Pediatr Orthop. 1991 Mar-Apr. 11(2):149-53. [Medline].

  70. Kaneko H, Kitoh H, Mishima K, Matsushita M, Ishiguro N. Long-term outcome of gradual reduction using overhead traction for developmental dysplasia of the hip over 6 months of age. J Pediatr Orthop. 2013 Sep. 33(6):628-34. [Medline].

  71. Terjesen T, Horn J, Gunderson RB. Fifty-Year Follow-up of Late-Detected Hip Dislocation: Clinical and Radiographic Outcomes for Seventy-one Patients Treated with Traction to Obtain Gradual Closed Reduction. J Bone Joint Surg Am. 2014 Feb 19. 96(4):e28. [Medline].

  72. Fleissner PR Jr, Ciccarelli CJ, Eilert RE, Chang FM, Glancy GL. The success of closed reduction in the treatment of complex developmental dislocation of the hip. J Pediatr Orthop. 1994 Sep-Oct. 14(5):631-5. [Medline].

  73. Schoenecker PL, Strecker WB. Congenital dislocation of the hip in children. Comparison of the effects of femoral shortening and of skeletal traction in treatment. J Bone Joint Surg Am. 1984 Jan. 66(1):21-7. [Medline]. [Full Text].

  74. Wenger DR, Lee CS, Kolman B. Derotational femoral shortening for developmental dislocation of the hip: special indications and results in the child younger than 2 years. J Pediatr Orthop. 1995 Nov-Dec. 15(6):768-79. [Medline].

  75. Gholve PA, Flynn JM, Garner MR, Millis MB, Kim YJ. Predictors for secondary procedures in walking DDH. J Pediatr Orthop. 2012 Apr-May. 32(3):282-9. [Medline].

  76. Rebello G, Zilkens C, Dudda M, Matheney T, Kim YJ. Triple pelvic osteotomy in complex hip dysplasia seen in neuromuscular and teratologic conditions. J Pediatr Orthop. 2009 Sep. 29(6):527-34. [Medline].

  77. Clohisy JC, Barrett SE, Gordon JE, Delgado ED, Schoenecker PL. Periacetabular osteotomy for the treatment of severe acetabular dysplasia. J Bone Joint Surg Am. 2005 Feb. 87(2):254-9. [Medline].

  78. Roposch A, Wedge JH. An incomplete periacetabular osteotomy for treatment of neuromuscular hip dysplasia. Clin Orthop Relat Res. 2005 Feb. 431:166-75. [Medline].

 
Previous
Next
 
Galeazzi sign is classic identifier of unilateral hip dislocation. Patient lies supine, with hips and knees flexed. Examination should demonstrate that one leg appears shorter than other. Although this appearance is usually due to hip dislocation, it is important to realize that any limb-length discrepancy results in positive Galeazzi sign.
Typical radiographic evaluation of developmental dysplasia of hip (DDH). From anteroposterior radiograph of hips, horizontal line (Hilgenreiner line) is drawn between each triradiate cartilage. Next, lines are drawn perpendicular to Hilgenreiner line through superolateral edge of acetabulum (Perkin line), dividing hip into 4 quadrants. Proximal medial femur should be in lower medial quadrant, or ossific nucleus of femoral head, if present (usually observed in patients aged 4-7 months), should be in lower medial quadrant. Acetabular index is angle between Hilgenreiner line and line drawn from triradiate cartilage to lateral edge of acetabulum. Typically, this angle decreases with age and should measure less than 20° by 2 years of age. Shenton line is drawn from medial aspect of femoral neck to inferior border of pubic rami. It should create smooth arc that is not disrupted. Disruption of Shenton line indicates presence of some degree of hip subluxation.
Radiographs from 6-year-old child who underwent open reduction with capsular plication, femoral shortening, and pelvic (Pemberton) osteotomy.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.